Antitumor Potential of the Isoflavonoids (+)- and (−)-2,3,9-Trimethoxypterocarpan: Mechanism-of-Action Studies

ACS Medicinal Chemistry Letters
2020.0

Abstract

Synthetically derived samples of (+)-(6a<i>S</i>,11a<i>S</i>)-2,3,9-trimethoxypterocarpan [(+)-<b>1</b>] and its enantiomer [(-)-<b>1</b>], both of which are examples of naturally occurring isoflavonoids, were evaluated, together with the corresponding racemate, as cytotoxic agents against the HL-60, HCT-116, OVCAR-8, and SF-295 tumor cell lines. As a result it was established that compound (+)-<b>1</b> was particularly active with OVCAR-8 cells being the most sensitive and responding in a dose-dependent manner. A study of cell viability and drug-induced morphological changes revealed the compound causes cell death through a mechanism characteristic of apoptosis. Finally, a computational study of the interactions of compound (+)-<b>1</b> and (<i>S</i>)-monastrol, an established, synthetically derived, potent, and cell-permeant inhibitor of mitosis, with the kinesin-type protein Eg5 revealed that both bind to this receptor in a similar manner. Significantly, compound (+)-<b>1</b> binds with greater affinity, an effect attributed to the presence of the associated methoxy groups.

Knowledge Graph

Similar Paper